Key Record Dates
ClinicalTrials.gov Identifier: | NCT03918278 |
---|---|
Brief Title: | A Study of MK-0482 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-0482-001) |
First Submitted : | April 15, 2019 |
First Submitted that Met QC Criteria : | April 15, 2019 |
First Posted : | April 17, 2019 |
Last Update Submitted that Met QC Criteria : | May 24, 2023 |
Last Update Posted : | May 25, 2023 |